Univest Financial’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.8M | Buy |
20,546
+2,127
| +12% | +$1.12M | 0.65% | 40 |
|
|
2025
Q1 | $11.7M | Buy |
18,419
+4,217
| +30% | +$2.67M | 0.76% | 30 |
|
|
2024
Q4 | $10.1M | Sell |
14,202
-1,514
| -10% | -$1.08M | 0.64% | 42 |
|
|
2024
Q3 | $16.5M | Buy |
15,716
+10,024
| +176% | +$10.5M | 1.09% | 25 |
|
|
2024
Q2 | $5.98M | Sell |
5,692
-158
| -3% | -$166K | 1.66% | 17 |
|
|
2024
Q1 | $5.63M | Sell |
5,850
-1,159
| -17% | -$1.12M | 1.58% | 21 |
|
|
2023
Q4 | $6.16M | Sell |
7,009
-115
| -2% | -$101K | 1.82% | 16 |
|
|
2023
Q3 | $5.86M | Buy |
7,124
+448
| +7% | +$369K | 1.96% | 12 |
|
|
2023
Q2 | $4.8M | Sell |
6,676
-474
| -7% | -$341K | 1.45% | 22 |
|
|
2023
Q1 | $5.87M | Buy |
7,150
+2,107
| +42% | +$1.73M | 1.83% | 15 |
|
|
2022
Q4 | $3.64M | Sell |
5,043
-998
| -17% | -$720K | 1.15% | 33 |
|
|
2022
Q3 | $4.16M | Buy |
+6,041
| New | +$4.16M | 1.36% | 22 |
|